ACKR1 genotype/Duffy phenotype | ||
Duffy-null¶ | Non-Duffy-null | |
Hemolytic transfusion reactions (HTRs)Δ |
|
|
Hemolytic disease of the fetus and newborn (HDFN)◊ |
|
|
ANC normal range |
|
|
Risk of infections |
|
|
Drug dosing | Drug dosing should not be altered based on baseline ANC (consider Duffy-null specific reference ranges). | |
Relatives | May benefit from knowing their status for reasons mentioned above. |
ACKR1: atypical chemokine receptor 1; ANC: absolute neutrophil count; Fy: Duffy antigen; HDFN: hemolytic disease of the fetus and newborn; HIV: human immunodeficiency virus; HTR: hemolytic transfusion reaction; P. knowlesi: Plasmodium knowlesi; P. vivax: Plasmodium vivax; RBC: red blood cell.
¶ Other designations for Duffy-null include:Δ Pretransfusion testing is routinely used to avoid antigens implicated in hemolytic transfusion reactions.
◊ Maternal antibody screen is routinely performed during pregnancy to identify risk for HDFN and the need for additional testing and monitoring. Only anti-Fya has been associated with HDFN.